Drug Type Small molecule drug |
Synonyms MTL 005 |
Target |
Action stimulants |
Mechanism Reactive oxygen species stimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC38H42B20CuN6O6 |
InChIKeyWZFUJPJMMMMMDJ-UHFFFAOYSA-N |
CAS Registry1030303-53-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Head and Neck Neoplasms | Phase 1 | United Kingdom | - | |
Breast Cancer | Preclinical | United Kingdom | - |